New EkoSonic™ Endovascular System with Rapid Pulse™ Modulation
In Laboratory in vitro testing, the EkoSonic system dissolved thrombus twice as fast as earlier EKOS systems - and four times faster than conventional catheter - directed thrombolysis. With no evidence of thrombus breakage. And no hemolysis.
The EkoSonic™ Endovascular System is intended for the controlled and selective infusion of physician – specified fluids including thrombolytics, into the peripheral vasculature. The EkoSonic™ Endovascular System is also intended for the infusion of solutions into the Pulmonary Arteries.
The Safety and effectiveness of the EkoSonic™ Endovascular System for thrombolytic therapy administration in pulmonary embolus have not been established. In particular, the ultrasound energy delivered by the EkoSonic System is not intended to be therapeutic, nor has it been cleared with an indication for thrombolysis in pulmonary emboli.
With Rapid Pulse™ Modulation
The innovation behind this breakthrough is EKOS Rapid Pulse™ Modulation, which manipulates the amplitude and duration of the microsonic energy released into the clot to optimize its impact. In laboratory tests with identical samples, Rapid Pulse Modulation demonstrated greater clot permeability and drug penetration, resulting in accelerated dissolution.



